You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STAT3 Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)

Recruiting
  • Brain Tumor
  • +2 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta (CHOA)
Jul 24, 2022

Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

Recruiting
  • Breast Cancer
  • Saint Louis, Missouri
  • +2 more
Jan 12, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial in Boston (pyrimethamine)

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Breast Cancer, Head and Neck Squamous Cell Carcinoma, Non Small Cell Lung Cancer Trial in Atlanta, Houston, San Antonio

Recruiting
  • Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Jun 13, 2022

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (STAT

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • STAT Inhibitor OPB-111077
  • +3 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 20, 2022

MDS Trial in Bronx (Pyrimethamine)

Withdrawn
  • Myelodysplastic Syndromes
  • Bronx, New York
    Montefiore Medical Center
Sep 15, 2021

Solid Tumor, Adult, Refractory Tumor Trial in Dallas, San Antonio (DCR-STAT3)

Recruiting
  • Solid Tumor, Adult
  • Refractory Tumor
  • Dallas, Texas
  • +1 more
Oct 21, 2023

Investigating STAT3 as a Driver of Pathology in Periodontitis

Recruiting
  • Periodontitis
  • no intervention
  • Santiago, Chile
    Faculty of Dentistry, University of Chile
Aug 16, 2022

Genetics of Hyperimmunoglobulin E Recurrent Infection Syndrome

Recruiting
  • Infections
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Genetic Analysis of Immune Disorders

    Recruiting
    • DOK 8
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 27, 2023

      Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Miami, Florida
        University of Miami
      Jun 27, 2022

      Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • (no location specified)
      Dec 20, 2022

      Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • (no location specified)
      Oct 31, 2023

      Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain Trial in Los Angeles, Torrance (Tart

      Not yet recruiting
      • Breast Cancer
      • +2 more
      • Tart Cherry
      • Omega 3 FA (Fish Oil)
      • Los Angeles, California
      • +1 more
      Nov 7, 2023

      Cushing Disease Trial (Fimepinostat)

      Not yet recruiting
      • Cushing Disease
      • (no location specified)
      Jul 31, 2023

      Novel Genetic Disorders of the Immune System

      Recruiting
      • PI3KCD
      • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)

        Completed
        • Relapsed or Refractory Lymphoma
        • Itraconazole 200 mg
        • +3 more
        • Miami, Florida
          QPS- Miami
        Jan 12, 2023

        Healthy Volunteers Trial (Brensocatib, Clarithromycin)

        Not yet recruiting
        • Healthy Volunteers
        • (no location specified)
        Jul 19, 2023

        Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

        Recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Oklahoma City, Oklahoma
        • +1 more
        Nov 13, 2023

        Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)

        Active, not recruiting
        • Breast Cancer
        • Guangzhou, Guangdong, China
          State Key Laboratory of Oncology in South China, Sun Yat-sen Uni
        Jan 27, 2023

        Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Gdansk (WP1220)

        Completed
        • Cutaneous T-Cell Lymphoma/Mycosis Fungoides
        • Gdansk, Poland
          Medical University of Gdansk
        Jan 8, 2021

        Primary Aldosteronism, Endocrine Hypertension Trial (Cinnarizine, NIFEdipine ER)

        Not yet recruiting
        • Primary Aldosteronism
        • Endocrine Hypertension
        • (no location specified)
        Jan 12, 2023

        Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

        Recruiting
        • Acute Myeloid Leukemia (AML)
        • Birmingham, Alabama
        • +2 more
        Jan 3, 2023

        Advanced Solid Tumor Trial in Beijing (Inosine 0.2g orally 3 times/day, PD-1/PD-L1 inhibitor ,chemo/targeting)

        Completed
        • Advanced Solid Tumor
        • Inosine 0.2g orally 3 times/day
        • PD-1/PD-L1 inhibitor ,chemotherapy/targeting
        • Beijing, Beijing, China
          Qin li
        Mar 30, 2023